BioStem Technologies, Inc. (BSEM)
2.73
-0.34
(-11.07%)
USD |
NASDAQ |
Oct 02, 16:00
2.73
0.00 (0.00%)
After-Hours: 20:00
BioStem Technologies Gross Profit Margin (Quarterly) : 52.55% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.55% |
| March 31, 2026 | 52.47% |
| December 31, 2025 | 96.56% |
| September 30, 2025 | 87.95% |
| June 30, 2025 | 93.20% |
| March 31, 2025 | 94.32% |
| December 31, 2024 | 84.16% |
| September 30, 2024 | 76.69% |
| June 30, 2024 | 94.90% |
| March 31, 2024 | 94.57% |
| December 31, 2023 | 93.88% |
| September 30, 2023 | 89.11% |
| June 30, 2023 | 75.09% |
| March 31, 2023 | 72.31% |
| December 31, 2022 | 76.94% |
| September 30, 2022 | 73.82% |
| June 30, 2022 | 86.18% |
| March 31, 2022 | 87.64% |
| December 31, 2021 | 51.64% |
| September 30, 2021 | 56.84% |
| Date | Value |
|---|---|
| June 30, 2021 | 44.80% |
| March 31, 2021 | 59.01% |
| December 31, 2020 | 64.98% |
| September 30, 2020 | 32.70% |
| June 30, 2020 | -13.19% |
| March 31, 2020 | 37.75% |
| June 30, 2019 | 33.88% |
| March 31, 2019 | 28.98% |
| December 31, 2018 | -0.54% |
| September 30, 2018 | 63.94% |
| June 30, 2018 | -43.91% |
| March 31, 2018 | -16.59% |
| December 31, 2017 | 33.50% |
| September 30, 2017 | -189.0% |
| June 30, 2017 | 43.92% |
| March 31, 2017 | 57.54% |
| December 31, 2016 | 39.01% |
| September 30, 2016 | 60.98% |
| June 30, 2016 | 60.98% |
| March 31, 2016 | 77.33% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 75.66% |
| Eloxx Pharmaceuticals, Inc. | -- |
| Wave Life Sciences, Inc. | -4.27% |
| Axsome Therapeutics, Inc. | 92.47% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.90% |
| Return on Assets | -42.98% |
| Return on Invested Capital | -66.87% |
| Profit Margin (Quarterly) | -113.6% |
| Operating Margin (Quarterly) | -106.3% |
| Return on Net Operating Assets | -64.56% |